C-QF1Rgeneric medicines, specialty medicines, AI drug discovery
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Algorae Pharma (prev Living Cell Technologies) generic medicines, specialty medicines, AI drug discovery
Algorae Pharmaceuticals Limited is an Australian pharmaceutical company listed on the Australian Securities Exchange under ASX: 1AI. Its AlgoraeRx division sources, registers, and supplies generic and specialty medicines for Australian and New Zealand markets through manufacturer partnerships. Its AlgoraeOS platform is an AI-powered drug discovery system developed with UNSW AI Institute and CSIRO Data 61 and independently validated at the Peter MacCallum Cancer Centre.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Algorae Pharma (prev Living Cell Technologies) — Translational · Bottom quartile. Derived deterministically from 4 extracted project(s). Most-advanced status: phase 2. Band: translational. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic